The Deal Everyone Takes, and What It Costs
A major cosmetics company approaches a top-tier recording artist. The offer: $2.5 million for a 12-month brand ambassador contract. Your face on the campaign, a handful of appearances, maybe a co-branded product with your name on it. The check clears in 30 days. Management takes 15%, business manager takes another 3%, the IRS takes 37%. Net proceeds: roughly $1.1 million.
That is a good day's work by almost any measure. Most artists say yes, and no one can fault them for it. But that yes — made reflexively, without modeling the alternative — may be the most expensive financial decision of their careers.
The alternative is equity. And the math behind it is not close.
What an Endorsement Deal Actually Pays
Let's be precise about endorsement economics. Top-tier celebrity endorsement deals in beauty and consumer goods range from $500,000 for emerging talent to $5 million or more for global icons. The structure is almost always the same: a flat fee (sometimes with a small royalty on co-branded SKUs, rarely exceeding 3-5% of net sales), a limited term (typically 12-24 months), and a renewal option that resets the negotiation. The brand owns every asset created. The brand controls whether the line continues. The artist's upside is capped the moment they sign.
There is no residual. There is no compounding. There is no exit event. You trade your cultural authority for a one-time payment, and the transaction is complete.
The Equity Structure: Where Upside Lives
Equity in a consumer brand works differently. In the simplest scenario, an artist co-founds or takes an ownership stake in a brand — typically 20-51% depending on how much operational infrastructure their partner brings. That stake represents a claim on every dollar of future enterprise value the company creates.
The mechanics of a beauty brand exit are well-established. Consumer beauty companies are acquired at revenue multiples ranging from 3x to 5x annual revenue at the time of sale, with premiums for high-growth trajectories, proprietary formulations, and loyal communities. A brand generating $50 million in annual revenue exits at $150-250 million. A 30% equity stake in that exit is $45-75 million. That is the floor, not the ceiling.
Consider the mid-case scenario more carefully. A brand reaches $80 million in annual revenue over five years. Exit multiple is 4x. Enterprise value at exit: $320 million. A 30% equity stake returns $96 million — net of taxes, still roughly $60-65 million to the artist. The endorsement deal that looked attractive at $2.5 million now looks like it was priced at a 96% discount to the equity alternative.
Three Case Studies That Define the Gap
Fenty Beauty (Rihanna). When Rihanna partnered with LVMH to launch Fenty Beauty in September 2017, the conventional wisdom was skeptical. Celebrity beauty brands had a mixed track record, and LVMH was taking a significant bet. Rihanna's alternative — a traditional endorsement deal with a luxury beauty house of her profile — would have generated approximately $4-6 million. Instead, Fenty Beauty generated $100 million in revenue in its first 40 days. By year two, revenue exceeded $570 million. The brand reached a $2.8 billion valuation. Rihanna's equity stake has made her the wealthiest female musician alive, with a net worth LVMH itself has confirmed is predominantly driven by Fenty holdings — not music royalties, not touring. The endorsement path would have paid for a house. The equity path built a fortune of a different order entirely.
Rare Beauty (Selena Gomez). Selena Gomez launched Rare Beauty in September 2020 with Kendo (the LVMH-owned brand incubator that also houses Fenty). She brought no manufacturing infrastructure, no existing distribution, and no prior beauty brand. What she brought was 200 million Instagram followers, a deeply personal mental health narrative, and a clear point of view on what the brand stood for. Three years from launch, Rare Beauty reached a valuation exceeding $2 billion — with some estimates placing it higher following 2023 acquisition conversations. Gomez's endorsement alternative: a fragrance deal and a cosmetics ambassador contract, plausibly worth $3-5 million combined. Her equity in Rare Beauty is worth orders of magnitude more. The brand achieved this without a single dollar of traditional advertising in its first year.
Casamigos (George Clooney, Rande Gerber, Mike Meldman). Clooney's case is structurally different because it is not a beauty brand, but the equity economics are identical. He and his partners founded Casamigos tequila in 2013 — not as a business strategy initially, but because they were ordering personal supplies from a Mexican distillery in such volume that the distillery asked them to formalize the relationship. They launched commercially, grew to 120,000 cases in year one without traditional advertising, and Diageo acquired the company in June 2017 for $700 million upfront plus $300 million in performance earn-outs. A celebrity endorsement deal for a spirits brand at Clooney's profile in 2013 would have generated $2-4 million. His equity share of the Diageo transaction returned well over $200 million by most estimates. The gap: 50-100x.
The Jordan Brand Lesson: When Equity Never Stops
The most instructive example of equity economics in celebrity partnerships is the one that predates modern celebrity brands: Michael Jordan's deal with Nike. In 1984, Jordan was a rookie who had already been turned down by Adidas and Converse before signing with Nike. The deal included an unusual provision: instead of a flat royalty, Jordan received equity economics tied to Nike's "Air Jordan" sub-brand. The original deal was worth $500,000 per year over five years plus royalties — considered generous at the time.
In 2026, Jordan Brand generates over $7 billion in annual revenue for Nike. Jordan receives royalties on every dollar of that revenue. His basketball career ended decades ago. His endorsement economics are perpetual. This is what an equity-aligned structure delivers over a long enough time horizon: cash flows that outlast the career that created them.
No flat endorsement fee, regardless of size, replicates this outcome. A $50 million signing bonus in 1984 would have been extraordinary — and it would have been worth less than a single year of current Jordan Brand royalties.
The 50-200x Range: What Determines Your Multiple
The specific return gap between endorsement and equity depends on three variables working in combination. First, equity percentage: a 15% stake in a $500 million exit returns $75 million; a 40% stake returns $200 million. Negotiating your ownership percentage at founding is the highest-leverage moment in the entire arc of a celebrity brand. Second, exit multiple: beauty companies exit at 3-5x revenue. At the low end of a moderate-revenue scenario, the multiple compresses your return; at the high end, it amplifies it dramatically. Building a brand in a high-margin, high-retention category (skincare over color cosmetics, fragrance over body care) directly impacts exit multiple. Third, timeline: compounding at the brand level works the same way it works in finance. A brand that achieves $20 million in revenue in year two and $80 million in year five is not just a better business — it is worth disproportionately more at exit because acquirers pay for trajectory, not current revenue alone.
The 50x case is a conservative outcome: small equity stake, modest exit multiple, unremarkable timeline. The 200x case is not hypothetical — it describes what happened to Rihanna relative to the endorsement alternative.
Why the Equity Path Requires the Right Infrastructure
The reason most artists default to endorsement deals is not ignorance of the math. It is the infrastructure gap. Equity requires building an actual company: product development, manufacturing relationships, regulatory compliance, retail distribution, inventory financing, supply chain management, and an operational team. A flat endorsement fee requires a signature. The asymmetry in effort is real.
This is the specific problem Starpower solves for LatAm artists. The K-beauty manufacturing infrastructure — led by Korea's tier-1 OEM/ODM houses, whose founders and CEOs Tejune counts as personal friends — has compressed the timeline from brand concept to retail-ready product to 9-14 months. The Atypical Beauty distribution network already operates across the region. The brand incubation infrastructure exists. What has been missing is the bridge: a structured pathway that brings celebrity cultural authority together with Korean manufacturing excellence and LatAm distribution reach, under an equity structure that creates long-term wealth rather than a one-time check.
The math is established. The infrastructure exists. The only remaining variable is whether LatAm's most powerful artists claim the equity path before the window closes — or watch the next generation of beauty billionaires emerge from a market that their audiences already own.